- Home
- CODA vs VOR Comparison
CODA vs VOR Comparison
Compare CODA & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- VOR
- Stock Information
- Founded
- CODA 1994
- VOR 2015
- Country
- CODA United States
- VOR United States
- Employees
- CODA N/A
- VOR N/A
- Industry
- CODA Industrial Machinery/Components
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- CODA Industrials
- VOR Health Care
- Exchange
- CODA Nasdaq
- VOR Nasdaq
- Market Cap
- CODA 92.5M
- VOR 85.7M
- IPO Year
- CODA N/A
- VOR 2021
- Fundamental
- Price
- CODA $6.94
- VOR $0.15
- Analyst Decision
- CODA Strong Buy
- VOR Buy
- Analyst Count
- CODA 1
- VOR 7
- Target Price
- CODA $11.00
- VOR $7.83
- AVG Volume (30 Days)
- CODA 44.8K
- VOR 1.3M
- Earning Date
- CODA 06-11-2025
- VOR 05-20-2025
- Dividend Yield
- CODA N/A
- VOR N/A
- EPS Growth
- CODA 61.24
- VOR N/A
- EPS
- CODA 0.34
- VOR N/A
- Revenue
- CODA $21,064,685.00
- VOR N/A
- Revenue This Year
- CODA $11.64
- VOR N/A
- Revenue Next Year
- CODA $14.53
- VOR N/A
- P/E Ratio
- CODA $20.42
- VOR N/A
- Revenue Growth
- CODA 15.63
- VOR N/A
- 52 Week Low
- CODA $5.76
- VOR $0.15
- 52 Week High
- CODA $9.89
- VOR $1.87
- Technical
- Relative Strength Index (RSI)
- CODA 58.52
- VOR 14.55
- Support Level
- CODA $6.41
- VOR $0.65
- Resistance Level
- CODA $6.95
- VOR $0.85
- Average True Range (ATR)
- CODA 0.38
- VOR 0.07
- MACD
- CODA 0.05
- VOR -0.05
- Stochastic Oscillator
- CODA 78.78
- VOR 2.67
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.